Laboratory Reagents

Added: Aug 03, 2015 12:46 pm Modified: Sep 02, 2015 12:41 pmTrack Changes N00406-15-T-0517_Amendment 0001



Revisions have been made to Exhibits A~W which is a separate attachment entitled:



N00406-15-T-0517_Exhibits A~W_Rev.1

Added: Aug 03, 2015 12:46 pm SYNOPSIS:

This is a Sources Sought Synopsis for the purpose of conducting market research and obtaining industry information only. The Navy will use information obtained through this synopsis to develop an acquisition strategy. No proposals are being requested nor accepted at this time. No reimbursement will be made for any costs associated with providing information in response to this announcement. THIS IS NOT A SOLICITATION FOR PROPOSALS AND NO CONTRACT SHALL BE AWARDED FROM THIS SYNOPSIS.



NAVSUP Fleet Logistics Center Puget Sound is conducting market research to identify potential sources with the capacity and technical capability necessary to successfully perform the requirements described herein.





OBJECT:

The subject requirement is for brand name manufacturer’s reagents. The following manufacturer’s reagents are required: Alere, Bayer Diagnostics, Bio Laboratories, American Master Tech Scientific, Beckman Coulter, Bio Test Medical, Azer Scientific, Becton Dickinson, BioMerieux Vitek, Cancer Diagnostics, Fisher Scientific, Immucor Gamma, Lav Pulse Med/Energy Beam Sci 2, Ortho Clinical Diagnostics, Polymed Co, Remel, Simmler, Terumo, Trinity Biotech, Whatman, Dynarex, Globe Scientific, Kimberly Clark, LifeSign, Pacific Hemostasis, Quantimetrix, Sakura Finetek, Smiths Medical, Thermo Scientific, Wampole Lab/Inverness, Wilkens Anderson Co, EN Sciences, HemoCue, Kimble Chase, Orasure Tech, Phlebotic, Quidel, Siemens Medical, Streck Laboratories, Triangle Biomedical, and Wescor.





PERIOD OF PERFORMANCE:

1 October 2015 – 30 September 2016

2 Option Years



PLACE OF PERFORMANCE:

Medical reagents are required to be shipped from the manufacturer’s facility directly to U.S. Naval Hospitals in Yokosuka and Okinawa, Japan, Branch Medical Clinics located in Atsugi, Iwakuni, and Sasebo, Japan, and the Health Service Department in Diego Garcia in accordance with the delivery schedule.



RESPONSES:

The Government will use responses to this Sources Sought Notice to make appropriate acquisition decisions. Any resultant contract is anticipated to be a Firm-Fixed Price type of contract. Interested firms must demonstrate in their capability statement that they are qualified to perform under NAICS code 325412.



Responses should be emailed to cari.burnham@navy.mil with the words Sources Sought Response in the subject line.

Please indicate your firm’s name, phone number, email address, DUNS number, CAGE code, and point of contact. Interested parties must be registered in System for Award Management (SAM) as prescribed in FAR Clause 52.204-7 for responses to be valid.



Feedback and/or evaluation information will not be provided to any firm regarding their individual capability statements in response to the Source Sought Notice.



The deadline for submitting capability statements in response to the Sources Sought Notice is 6 August 2015 by 2:00 p.m. PDT.